IP Library Granted Patent US 7,704,528
Granted Patent B2
US 7,704,528 · App. 10/641,878 · Granted Apr 27, 2010

Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,704,528
App. No.
10/641,878
Granted
Apr 27, 2010
Kind
B2
Abstract

Tablets of a poorly compressible drug are made by direct compression using a binder composition which is a polymer, preferably a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate (VA), having a defined glass transition temperature (Tg), admixed with a plasticizer, e.g. an organic ester or polyol, which reduces the Tg of the copolymer by at least 10° C. The binder composition and the drug are directly compressed into a tablet of predetermined hardness and friability, and at an acceptable compression force.

Claims (17)

1. A process for making tablets of a poorly compressible drug by direct compression, which comprises providing a binder composition which is made by spray drying an aqueous dispersion of a copolymer of polyvinylpyrrolidone (PVR) and vinyl acetate (VA), having a defined glass transition temperature (Tg), and an effective amount of 5-15 wt. % of a plasticizer which is an organic ester or polyol therewith to reduce the Tg of said copolymer by at least 20° C., admixing said binder composition and 50-90 wt. % of said drug, and forming a tablet thereof by direct compression having a predetermined hardness and friability, and at an acceptable compression force.

2. A process according to claim 1 wherein said drug is naproxen or acetaminophen.

3. A process according to claim 1 wherein said copolymer comprises 60 wt. % PVP and 40% VA, having a Tg of about 106° C.

4. A process according to claim 1 wherein the binder composition is a free-flowing powder having an average particle size of about 30-90μ.

5. A process according to claim 1 wherein said plasticizer is triethyl citrate.

6. A process according to claim 1 wherein direct compression is carried out at 3000-7000 lbs. and the tablet has a hardness of at least about 8 kP and a friability of less than about 3.

7. A process according to claim 6 wherein said tablet hardness is about 8-30 kP, and said friability is about 1-3.

8. A binder composition for direct compression of a poorly compressible drug, comprising a free-flowing powder which is a spray dried aqueous dispersion of a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate (VA), and an effective amount of 5-15 wt. % of a plasticizer which is an organic ester or polyol to reduce the Tg of the polymer by at least 20° C.

9. A binder composition according to claim 8 wherein said copolymer comprises 60 wt. % PVP and 40 wt. % VA, having a Tg of about 106° C.

10. A binder composition according to claim 8 which has an average particle size of about 30-90μ.

11. A binder composition according to claim 8 wherein said plasticizer is triethyl citrate or polyethylene glycol.

12. A binder composition according to claim 8 in which said spray drying is carried out in the presence of silica powder.

13. A mixture of a poorly compressible drug and the binder composition of claim 8 .

14. A mixture according to claim 13 which also includes other excipients.

15. A drug tablet formed by the process of claim 1 .

16. A drug tablet of claim 15 in which said drug is naproxen or acetaminophen.

17. A drug tablet of claim 15 wherein said drug is present in an amount of about 50-90 wt. % therein.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
PATENT RELEASE Recorded Sep 19, 2011
From: JPMORGAN CHASE BANK, N.A. (F/K/A THE CHASE MANHATTAN BANK)
To: ISP CAPITAL, INC.; ISP CHEMICAL PRODUCTS, INC.; VERONA, INC.
Reel/Frame 026930/0774 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2003
From: HALDAR, RAMA; ZAMORA, JOHN; RAY, DIPAN B.; DREFKO, WILLIAM; DUBROWNY, GREG; ETIENNE, SIDNEY
To: ISP INVESTMENTS INC.
Reel/Frame 014407/0172 →